Combining red light therapy and special glasses to control myopia in children
Official title: Myopia Control Combined PBM With Myopic Defocus Lens in Children: Double-blind RCT for 6 Month
Run by Beijing Airdoc Technology Co., Ltd. · NCT05756959 · Data updated 2026-11-12
This study is testing whether red light therapy or special glasses can help slow down worsening eyesight in children aged 6 to 13 who have myopia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 13 Years |
| Sex | All |
| Enrollment | 304 (estimated) |
| Sponsor | Beijing Airdoc Technology Co., Ltd. Industry-sponsored |
| Locations | 1 site (Xuzhou, Jiangsu) |
| Status | Recruiting |
| Started | December 12, 2022 |
| Main results expected | August 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 9, 2023 |
| Trial ID | NCT05756959 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 6 to 13 years with myopia ranging from -0.50D to -5.50D and no other myopia control interventions in the last three months.
✕Probably not a fit
Patients with significant ocular diseases, systemic conditions, or those currently using other myopia control methods may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of two methods for controlling progressive myopia in children aged 6 to 13 years. Participants will be randomly assigned to receive either low-level red light therapy or peripheral defocus spectacles, with a control group receiving single vision spectacles. The study is designed as a prospective, double-blind, randomized trial lasting six months. The aim is to assess how these interventions impact the progression of myopia in young patients.
Why it matters
Potential benefit: If successful, this study could provide a new approach to effectively manage and slow the progression of myopia in children.
How similar studies have gone: While the combination of these specific interventions is novel, similar approaches in myopia control have shown promise in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed consent by the supervision of the children * 6\~13 years old (including both the 6 and 13) * SE range: -0.50\~-5.50D * Astigmatism \<=2.00D * BCVA \>=0.8 * Anisometropia \<=1.50D * Confirmed to no use of other myopia control intervention Exclusion Criteria: * Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential opitc abnormal and etc.) * Halo, glare, toutic, ADHD, psoriasis * Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction. * Squint, ocular lesion or acute imflammation. * Other myopia control interventions within recent 3 month such as atropine, device, orthokeratology, multi-focus soft lens, multi-function spectacles.
Where it's running
-
the first people's hospital of Xuzhou
Xuzhou, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Ying Li, MD, PHD
- Email: 834582241@qq.com
- Phone: +8615162130727
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating Atropine for Delaying Myopia in Children
This study is testing if a low-dose eye drop can help slow down worsening eyesight in children aged 3 to 12 who are becoming nearsighted.
-
Preventing myopia in children using distance-image screens
This study is testing a special screen to see if it can help prevent nearsightedness in kids aged 6 to 12 by having them use it for at least 2 hours a day for a year.
-
Comparing a new software for eye refraction with traditional methods
This study is testing a new eye refraction software called Mobilerone to see if it gives accurate results for adults and older children with nearsightedness and astigmatism compared to traditional methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.